Invention Grant
- Patent Title: Substituted quinoline compounds and methods of use
-
Application No.: US14824096Application Date: 2015-08-12
-
Publication No.: US09598400B2Publication Date: 2017-03-21
- Inventor: Ning Xi
- Applicant: CALITOR SCIENCES, LLC , SUNSHINE LAKE PHARMA CO., LTD.
- Applicant Address: US CA Newbury Park CN Dongguan, Guangdong
- Assignee: CALITOR SCIENCES, LLC,SUNSHINE LAKE PHARMA CO., LTD.
- Current Assignee: CALITOR SCIENCES, LLC,SUNSHINE LAKE PHARMA CO., LTD.
- Current Assignee Address: US CA Newbury Park CN Dongguan, Guangdong
- Agency: Squire Patton Boggs (US) LLP
- Agent Kam W. Law
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; A61K45/06 ; C07D401/12 ; A61K38/21 ; A61K31/436

Abstract:
The present invention provides novel substituted quinoline compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
Public/Granted literature
- US20150342945A1 SUBSTITUTED QUINOLINE COMPOUNDS AND METHODS OF USE Public/Granted day:2015-12-03
Information query
IPC分类: